Importantly, the reduced activity of the CYP2C8 enzyme due to polymorphic variants has been linked to both increased risk of breast cancer recurrence or absence of effects in colorectal cancer [57, 58], suggesting that the levels of the residual enzymatic activity and the kind of cancer are crucial to determine how the specific variation affects cancer progression. The gene discussed is CYP2C8; the disease is cancer.